论文部分内容阅读
类风湿关节炎(RA)是以关节滑膜炎症为主要表现的自身免疫性疾病,T细胞在RA的发病和进展中起关键性作用,以CD4+效应性T细胞尤为重要。近年来在自身免疫病和过敏原特异性反应研究中发现机体存在一种新的CD4+T细胞亚群,其具有白介素-23(IL-23)依赖性产生IL-17,发挥重要的免疫调节作用,而IL-17是其主要效应分子[1]。因此我们
Rheumatoid arthritis (RA) is an autoimmune disease mainly characterized by synovial inflammation of the joint. T cells play a key role in the pathogenesis and progression of RA, and CD4 + effector T cells are particularly important. In recent years, studies on autoimmune diseases and allergen-specific reactions have found that there is a new subset of CD4 + T cells in the body that has interleukin-23 (IL-23) -dependent IL-17 production and plays an important immunomodulatory IL-17 is its main effector molecule [1]. therefore, we